[ARS] Viatris Inc SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

10/24/2025 - 04:19 PM

ARS - Viatris Inc

ARS Filing - Viatris Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: Viatris Inc (VTRS)

Acceptance Date: 2025-10-24T16:19:02.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Viatris Inc Ord Shs

NASDAQ:VTRS

View VTRS Stock Overview →

VTRS Rankings

#697 Ranked by Market Cap

N/A Ranked by Dividends

VTRS Latest News

Mar 19, 2026

Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030

Feb 26, 2026

Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results

Feb 26, 2026

Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend

Feb 25, 2026

FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia

Feb 3, 2026

Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026

VTRS Latest SEC Filings

Mar 10, 2026

[Form 4] Viatris Inc Insider Trading Activity

Mar 10, 2026

[Form 4] Viatris Inc Insider Trading Activity

Mar 10, 2026

[Form 4] Viatris Inc Insider Trading Activity

Mar 10, 2026

[Form 4] Viatris Inc Insider Trading Activity

Mar 10, 2026

[Form 4] Viatris Inc Insider Trading Activity

VTRS Stock Data

Market Cap 15.82B

Float 1.15B

Industry Drug Manufacturers - Specialty & Generic

Sector Pharmaceutical Preparations

Website Link

Country United States

City CANONSBURG